Athenex, Inc. Profile Avatar - Palmy Investing

Athenex, Inc.

Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial …

Drug Manufacturers - Specialty & Generic
US, Buffalo [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ATNX's Analysis
CIK: 1300699 CUSIP: 04685N103 ISIN: US04685N1037 LEI: - UEI: -
Secondary Listings
ATNX has no secondary listings inside our databases.